Savitha M. Rao

Array ( [id] => 7778636 [patent_doc_number] => 20120041034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/187158 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14632 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041034.pdf [firstpage_image] =>[orig_patent_app_number] => 13187158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778636 [patent_doc_number] => 20120041034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/187158 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14632 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041034.pdf [firstpage_image] =>[orig_patent_app_number] => 13187158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778636 [patent_doc_number] => 20120041034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/187158 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14632 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041034.pdf [firstpage_image] =>[orig_patent_app_number] => 13187158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11773389 [patent_doc_number] => 09382226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'Aldosterone synthase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/811059 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32042 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7705825 [patent_doc_number] => 20120000806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'METHODS FOR REDUCING THE RISK OF AN ADVERSE DRONEDARONE / BETA-BLOCKERS INTERACTION IN A PATIENT SUFFERING FROM ATRIAL FIBRILATION' [patent_app_type] => utility [patent_app_number] => 13/172984 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5440 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13172984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9173909 [patent_doc_number] => 20130315895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET' [patent_app_type] => utility [patent_app_number] => 13/703861 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 87958 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13703861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580866 [patent_doc_number] => 20110294749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'DIAMINOPYRIMIDINECARBOXAMIDE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/171411 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30237 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294749.pdf [firstpage_image] =>[orig_patent_app_number] => 13171411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8625197 [patent_doc_number] => 08357692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-22 [patent_title] => 'Methods of treatment of bone degenerative diseases' [patent_app_type] => utility [patent_app_number] => 13/162960 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8761 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9046899 [patent_doc_number] => 08541454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Antiseptic based on bispyridinium alkanes' [patent_app_type] => utility [patent_app_number] => 13/156635 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4636 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13156635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10505253 [patent_doc_number] => 09233112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Pharmaceutical compositions of cefixime' [patent_app_type] => utility [patent_app_number] => 13/156146 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2845 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13156146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768079 [patent_doc_number] => 20120035207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Use of GABAA Receptor Agonists for the Treatment of Hearing, Vestibular and Attention Disorders, Intention Tremor and Restless Leg Syndrome' [patent_app_type] => utility [patent_app_number] => 13/152519 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2793 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035207.pdf [firstpage_image] =>[orig_patent_app_number] => 13152519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016871 [patent_doc_number] => 20110224238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => '6, 9-Disubstituted Purine Derivatives and Their Use for Treating Skin' [patent_app_type] => utility [patent_app_number] => 13/116636 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15991 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224238.pdf [firstpage_image] =>[orig_patent_app_number] => 13116636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8374941 [patent_doc_number] => 08257732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'Clay-based hemostatic agents and devices for the delivery thereof' [patent_app_type] => utility [patent_app_number] => 13/115699 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 6078 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13115699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9016426 [patent_doc_number] => 20130231390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'PHARMACEUTICAL COMPOSITION OF IBUPROFEN FOR INJECTION' [patent_app_type] => utility [patent_app_number] => 13/641921 [patent_app_country] => US [patent_app_date] => 2011-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8104 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8721277 [patent_doc_number] => 20130072495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'FUSED BICYCLIC KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/697819 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37291 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792785 [patent_doc_number] => 20130109754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'COMBINATION OF AN NSAID AND AN AMINO ACID' [patent_app_type] => utility [patent_app_number] => 13/696022 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5222 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8829961 [patent_doc_number] => 20130131006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'METHOD FOR INHIBITING THE INDUCTION OF CELL DEATH BY INHIBITING THE SYNTHESIS OR SECRETION OF AGE-ALBUMIN IN CELLS OF THE MONONUCLEAR PHAGOCYTE SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/697332 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 13241 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958624 [patent_doc_number] => 20110183011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'COMPOSITION AND METHOD FOR TOPICAL TREATMENT OF SKIN LESIONS' [patent_app_type] => utility [patent_app_number] => 13/079964 [patent_app_country] => US [patent_app_date] => 2011-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5908 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183011.pdf [firstpage_image] =>[orig_patent_app_number] => 13079964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958624 [patent_doc_number] => 20110183011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'COMPOSITION AND METHOD FOR TOPICAL TREATMENT OF SKIN LESIONS' [patent_app_type] => utility [patent_app_number] => 13/079964 [patent_app_country] => US [patent_app_date] => 2011-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5908 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183011.pdf [firstpage_image] =>[orig_patent_app_number] => 13079964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958624 [patent_doc_number] => 20110183011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'COMPOSITION AND METHOD FOR TOPICAL TREATMENT OF SKIN LESIONS' [patent_app_type] => utility [patent_app_number] => 13/079964 [patent_app_country] => US [patent_app_date] => 2011-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5908 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183011.pdf [firstpage_image] =>[orig_patent_app_number] => 13079964 [rel_patent_id] =>[rel_patent_doc_number] =>)